Atheronova Inc. | |
Stock Exchange | Other OTC |
EPS |
- |
Market Cap |
$83.69 K |
Shares Outstanding |
8.81 M |
Public Float |
2.58 M |
Address |
2301 Dupont Drive Irvine California 92612 United States |
Employees | - |
Website | - |
Updated | 07/08/2019 |
AtheroNova, Inc. is a biotechnology company. The company engages in the research and development, marketing, and sale of pharmaceutical preparations and pharmaceutical intellectual property. It develops intellectual property that uses certain pharmacological compounds for the treatment of atherosclerosis, which is the primary cause of various cardiovascular diseases. |